Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)

NCT02060656 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Gemcitabine
DRUG: Methylprednisolone
DRUG: Rituximab
DRUG: Cisplatin
DRUG: Lenalidomide

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]